Anthony Hagen

Articles by Anthony Hagen

Conference Coverage: European Hematology Association 2021 Virtual Congress

ByLaura Joszt, MA,Maggie L. Shaw,Anthony Hagen,Mary Caffrey

August 16th 2021

FDA to Reassess 6 Oncology Immunotherapy Indications Granted Accelerated Approval

ByRose McNulty,Anthony Hagen

March 12th 2021

The FDA will reassess 6 indications for immune checkpoint inhibitors that were granted accelerated approval but failed to prove clinical benefit in confirmatory trials.

For Staying Power, Diabetes Interventions May Need a Hands-on Element

ByAnthony Hagen

January 21st 2015

Latest Updated Articles

Conference Coverage: European Hematology Association 2021 Virtual Congress
August 16th 2021
For Staying Power, Diabetes Interventions May Need a Hands-on Element
January 21st 2015

Anthony Hagen

Articles by Anthony Hagen

Conference Coverage: European Hematology Association 2021 Virtual Congress

FDA to Reassess 6 Oncology Immunotherapy Indications Granted Accelerated Approval

For Staying Power, Diabetes Interventions May Need a Hands-on Element

Latest Updated Articles

Trending on AJMC

Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD

MRD-Guided CLL Treatment Duration: Personalization or Malpractice?

Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered

Blinatumomab Improves Outcomes, Toxicity in High-Risk Pediatric ALL: Martin Schrappe, MD, PhD

frontMIND Trial Shows PFS Benefit With Tafasitamab, Lenalidomide Combo in High-Risk DLBCL: Umberto Vitolo, MD